City's first medical genetics dept. set up in LNJP Hospital; CM inaugurates unit
While inaugurating the department on Thursday, CM Rekha Gupta said, 'There are lakhs of parents scrambling to save their children who are born with genetic disorders. They do not know where to go. This department will treat those children who are born with such disorders.'
Ms. Gupta also inaugurated a Lactation Management Unit (LMU), and Nucleic Acid Amplification Testing (NAT) Lab in the hospital.
Regarding the Lactation Management Unit (LMU), she said that the unit is designed to serve preterm, low-birth-weight, and critically ill new-borns. It will offer breastfeeding counselling, safe milk collection and storage, and hospital-grade breast pumps for mothers.
'Our goal is to ensure accessible, high-quality, and timely medical services for every citizen—regardless of age, background, or region. A healthy Delhi is the foundation of a developed Delhi. With this vision, three highly advanced health services have been launched, setting a new milestone in the city's medical infrastructure,' Ms. Gupta said.
This is the first Delhi government hospital to have a NAT Lab, she said, adding that screening reports, which used to take 45 days, will be available within two days here. The NAT is a highly sensitive diagnostic method capable of detecting viral infections like HIV, Hepatitis B, and C at an early stage.
The CM also criticised the state of the healthcare infrastructure that the BJP government inherited from previous government, calling it 'deeply concerning.' She added that while the World Health Organisation recommends a minimum of two beds per 1,000 population, not even one bed per 1,000 citizens is available in the Capital. She said that the Delhi government aims to ensure at least three beds per 1,000 people within the next five years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
6 hours ago
- Mint
When an HIV Scientific Breakthrough Isn't Enough
(Bloomberg Opinion) -- A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food and Drug Administration last month. Gilead Sciences' lenacapavir is so effective that global health leaders had started to cautiously talk about the end of an epidemic that continues to kill more than 600,000 people each year. We should be celebrating its arrival. Instead, aid groups and the countries most affected by HIV are reeling from the Trump administration's relentless attacks on the global health infrastructure. Instead of perfecting plans for a rollout of the medication, they are scrambling to ensure people with HIV have the drugs they need to survive. Last year, I wrote about the stunning — or as one HIV expert described it, 'spine-chilling'— results from a large study of lenacapavir. None of the women and adolescents who were given the twice-yearly injection in the trial became infected with HIV. In a second study involving men who have sex with men, and transgender individuals who have sex with men, the treatment was 96% effective. Even better, Gilead is working on a newer version that could potentially offer protection for a year or more. That's about as close to an HIV vaccine we're likely to get — at least for many years. It's also the world's best shot of achieving the goal of ending HIV by 2030. For low- and middle-income countries that continue to face frustratingly stubborn infection rates, a twice-yearly drug could be a game-changer. Although existing treatments of daily pills do an excellent job at preventing infection, getting people to use them consistently has been difficult. There is the stigma attached to the pills. Ensuring patients return for frequent testing and refills is also challenging — as is simply remembering to take them daily. Consider the typical day of a mom with a newborn and it's easy to understand how six months of protection could make a real difference in lowering HIV cases in women and infants. Some experts have even suggested lenacapavir is our best chance of wiping out new infections in children. That was before the Trump administration abruptly shut down USAID, the lead agency behind Pepfar. The global initiative to combat HIV/AIDS is credited with saving an estimated 26 million lives since its inception in 2003. Although the administration granted a limited waiver to allow some HIV services to continue, funding is significantly restrained. As health workers grapple with fewer resources, their focus has shifted to people living with HIV. 'When the chips are down, you safeguard treatment because those people will die if they don't get their antiretroviral,' says Linda-Gail Bekker, director of the Desmund Tutu HIV Centre at the University of Cape Town. And yet, she said, 'prevention we know is an absolute cornerstone to bringing this epidemic under control.' Because the situation is so dynamic, it's been difficult to capture what's happening on the ground. The best current model suggests the administration's actions could result in at least 70,000 additional new infections, and another 5,000 deaths in the next five years. UCLA infectious disease epidemiologist Dvora Joseph Davey says that in 2024, the eight public health clinics in Cape Town — where she is based — saw three infants who were HIV-positive at birth. In the first five months of this year, they've already seen three babies born with the infection. She knows there will be more. One pregnant woman with HIV recently came into the clinic and, at 37 weeks, her viral load was dauntingly high. She'd skipped picking up her last three-month supply of pills. The nurse she'd been seeing was let go as part of the funding cuts, and no one was available to do a blood draw at her last visit, Davey says. If the people who, in theory, should still be benefiting from global aid are falling through the cracks, what hope do we have for prevention? Prevention efforts have already been severely disrupted in some countries. Supply is responsible for some of the upheaval, but the more complicated problem is getting the drugs to the people who need them most. 'We need low-cost product and also a low-cost delivery mode,' says Carmen Pérez Casas, senior strategy lead at Unitaid, a global health initiative hosted by the World Health Organization. The situation for the latter 'has changed radically,' she says. HIV prevention is not as simple as just handing out a prescription. It's first identifying those most at risk of infection, getting them tested to confirm they are negative, and offering counseling about their options. It's ensuring they return for more testing and the next dose of their medication. That requires a vast support network ranging from doctors and nurses to counselors, pharmacists, lab technicians, data scientists and more. Pepfar supported all of that infrastructure. In South Africa, for example, cuts have resulted in lost jobs for some 8,000 health workers focused on HIV. Aid groups are doing their best to ensure the breakthrough's promise is not entirely lost. Their first hurdle is bridging the gap to the arrival of low-cost generic lenacapavir, which isn't expected until sometime in 2027. (Gilead is allowing a handful of drug companies to make and sell generic forms of lenacapavir in the countries most heavily impacted by HIV.) Global health agencies are anxiously awaiting the company's price tag for those countries to understand how far their funding can be stretched. Then they need to get the drug to patients. Experts tell me they've scaled back their expectations given the upheaval with Pepfar. The Trump administration's termination of National Institutes of Health grants to foreign countries has created additional hurdles. It's been particularly devastating in South Africa, where the NIH supported a significant chunk of research related to HIV. That means less money to conduct so-called implementation studies for lenacapavir, which are crucial for understanding how to improve the drug's use in the real world. One simple thing the Trump administration could do is free up funding for prevention. Pepfar continues to operate under a waiver that only allows PrEP money to be spent for those who are pregnant or breastfeeding. Groundbreaking science alone won't end HIV. It must be paired with affordability and access. The Trump administration's callous cuts to global health efforts put all of those things at risk — including the promising future where HIV is brought to heel. More From Bloomberg Opinion: This column reflects the personal views of the author and does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners. Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. More stories like this are available on
India Gazette
8 hours ago
- India Gazette
Union Health Minister JP Nadda, Delhi CM Rekha Gupta distribute appointment letters to 1400 nurses
New Delhi [India], July 6 (ANI): As Union Health Minister JP Nadda and Delhi Chief Minister Rekha Gupta distributed appointment letters to 1400 nurses on Sunday, CM Gupta said that the government is making efforts to tackle the shortage of medical staff and medicines. Rekha Gupta told the reporters, 'It is a matter of great joy that, after many years in the history of the Delhi government, appointment letters for permanent nursing staff have been distributed by the government. For years, due to a shortage of staff, Delhi's hospitals have been running in a disorganised manner. The government has made significant efforts within its tenure to fill these vacancies, and today, approximately 1,400 nurses have been given appointment letters.' Delhi CM further congratulated the health department and the Health Ministry. 'Our effort is to ensure that there is no shortage of medicines, doctors, staff, or infrastructure in Delhi's hospitals. From the bottom of our hearts, we extend heartfelt congratulations to the entire health department, the Health Ministry, and the Health Minister. We request everyone to come together and serve the people of Delhi,' CM Gupta said. During the same event, Union Minister Nadda and CM Rekha Gupta also flagged off Ayushman Bharat Registration Vans in Vigyan Bhawan on Sunday. Addressing the event, the BJP chief slammed the Aam Aadmi Party (AAP) for not using Rs 1700 crore under the Ayushman Bharat Scheme for public welfare. He said, 'Under PM-Ayushman Bharat Health Infrastructure Mission, we had given Rs 1700 crore to Delhi between 2021 to February 2025, but not one penny was spent, and now the responsibility of the expenditure of this fund for the public welfare has fallen on the shoulders of (Delhi CM) Rekha ji.' Continuing his attack against AAP, he added, 'We were ready to quench Delhi's thirst with water, but you kept the vessel upside down, so what could be done? On February 20, you turned up the vessel, so you got Ayushman Bharat. Prime Minister Narendra Modi was ready to provide Rs 5 lakh for the poor's healthcare since September 2, 2017. Their pride came in between. They did injustice to the poor.' Lauding Ayushman Arogya Mandir, Nadda targeted Aam Aadmi Mohalla Clinic and called AAP shortsighted. 'A wise man is farsighted and thinks of Ayushman Arogya Mandir, and shortsighted ones bring Mohalla Clinics. From the time a mother conceives a child to the time the child turns two, Ayushman Arogya Mandir takes care of all the vaccinations. India is playing a lead role in reproductive and child health care,' JP Nadda said. (ANI)
&w=3840&q=100)
Business Standard
9 hours ago
- Business Standard
1,300 nurses appointed in Delhi govt hospitals; Ayushman vans launched
The Delhi government on Sunday appointed over 1,300 new nursing officers and launched Ayushman Bharat registration vans to strengthen the healthcare system in the national capital. The event was attended by BJP president J P Nadda, Delhi Chief Minister Rekha Gupta, Health Minister Pankaj Singh, and other senior ministers. Addressing the gathering, Chief Minister Gupta sharply criticised the previous government, alleging that it had allowed the capital's health infrastructure to deteriorate significantly. "In the past, Delhi's healthcare was in such a poor state that there were only 0.42 hospital beds available per 1,000 people,she said. In 38 hospitals, there were only six MRI machines and 12 CT scan machines. Patients were frequently turned away due to a shortage of medicines, she added. Gupta further alleged widespread corruption under the Mohalla Clinics initiative. There was corruption in medicine procurement and hospital construction 22 hospitals were announced but never completed, she claimed. Speaking on the status of Arogya Mandirs, she stated that over ?1,700 crore was provided by the central government to the previous administration over a five-year period for their construction, but the funds remained unutilised. Now, it is my responsibility to ensure that all 1,150 Arogya Mandirs are completed in the remaining months, Gupta said. She added that 34 Arogya Mandirs have already been inaugurated, with several more to follow this month. We plan to add 100 Arogya Mandirs every month and aim to complete all 1,150 by March next year, she said. Delhi Health Minister Pankaj Singh, addressing the newly appointed staff, said their contribution would be crucial in strengthening the city's healthcare system. These nurses and health workers will become the backbone of a new, robust healthcare structure in the capital, he said. Singh also noted that nearly 4 lakh people have been registered under Ayushman Bharat in Delhi, including more than 2 lakh senior citizens above the age of 70. As many as 2,258 patients have already availed treatment under the scheme, he said. BJP president J P Nadda congratulated the new appointees and termed the occasion a historic moment. After 15 years, these nursing officers have finally received job security. This was not the result of a mere government order it is the outcome of the people of Delhi choosing the BJP, he said. He criticised the previous government for its alleged inaction across departments, especially in the health sector. Nadda pointed out that ?1,700 crore allocated in 2021 for improving Delhi's health infrastructure remained unused by the former administration. Now, under Chief Minister Rekha Gupta's leadership, it is our responsibility to ensure this amount is fully utilised in the next eight months to complete the Ayushman Mandirs, he said. Nadda also highlighted that since September 2017, the Modi government has approved free treatment of up to ?5 lakh for nearly 40 lakh residents of Delhi, particularly those living in slums and underprivileged areas. But the previous government blocked its implementation. Now, we are making it a reality, he added.
